Brief Background
Revista CEFAC (abbr. Rev. CEFAC; ISSN 1982-0216) is a peer-reviewed online scientific publication published by Associação Brasileira de Motricidade Orofacial (ABRAMO). Accepted articles are continuously published with open access under a Creative Commons Attribution License, in English and Portuguese or in Spanish, and organized in six annual editions. Revista CEFAC charges a publication fee. No submission fee is charged. Revista CEFAC was created in 1999 by Dr. Irene Queiroz Marchesan and Dr. Jaime Luiz Zorzi, the co-directors of CEFAC – Saúde e Educação. The materialization of what was a regularly discussed idea took place during the celebration of the CEFAC’s 15-year existence and was made possible thanks to the tenacity and partnership of individuals who always believed in producing and disseminating new knowledge related to speech therapy.
In 2016, Associação Brasileira de Motricidade Orofacial (ABRAMO) became responsible for publishing Revista CEFAC. To facilitate the understanding of the journal’s scope by readers and researchers around the world and thus increase its global visibility, in 2023 we began to adopt the acronym Current Evidence on Feeding, Audiology, and Communication - that is, CEFAC. |
Open Science Compliance
Revista CEFAC follows the Gold Open Access model.
The editorial policy of Revista CEFAC promotes transparency and open access to knowledge. We implement practices such as the publication of preprints and open access to all articles, ensuring that researchers, clinicians, and the general public can access the articles without restrictions. During manuscript submission, authors are required to complete the Open Science Compliance Form, where they provide information about the conformity of the manuscript with Open Science communication practices. |
Ethics in Publication
Revista CEFAC observes the “Guidelines on Best Practices for Strengthening Ethics in Scientific Publication” recommended by SciELO(1), which promote integrity and transparency in the dissemination and reproducibility of research, and the “Core Practices” of the Committee on Publication Ethics - COPE(2). Revista CEFAC values the maintenance of good scientific practices and publication ethics. All articles, following an initial technical evaluation, will be forwarded for similarity analysis using the Crossref Similarity Check by iThenticate to detect plagiarism. It should be noted that plagiarism is a crime punishable by Brazilian law. Fraudulent information or plagiarism is not accepted. In the case that plagiarism or self-plagiarism is detected, the author(s) will be notified, and the journal will adopt the retraction measures guided by SciELO(1), COPE(2) and the ICMJE. |
Focus and Scope
Revista CEFAC publishes Original Research Articles, Review Articles, Brief Communications, Case Reports, and Letters to the Editor that are relevant to speech-language pathology and audiology in the following areas: language, fluency, orofacial myofunctional disorders, voice, audiology, dysphagia, public health, neurofunctional speech therapy, gerontology, neuropsychology, work speech therapy and audiology, speech expertise, speech-language pathology in schools, and related areas. It also publishes other works that address the interfaces of speech-language pathology and audiology with other educational and health sciences. The mission of Revista CEFAC is to disseminate scientific advances related to different areas of speech-language pathology and audiology, as well as their interfaces with other areas of knowledge, in order to contribute to the growth and improvement of the quality of speech-language pathology and audiology at the national and international levels. |
Digital Preservation
This journal follows the standards set by SciELO Program Digital Preservation Policy. Revista CEFAC maintains electronic backup to preserve access to all its content through a partnership with Scientific Electronic Library Online (SciELO) via LOCKSS – Cariniana /IBICT. |
Indexing Sources
Bibliographic Journal Information
|
Websites and Social Media
|
Preprints
Revista CEFAC accepts manuscripts that have been deposited on a non-commercial preprint server, such as SciELO Preprints and EmeRI, as long as they are not being evaluated by another journal. The submission to the preprint server can be performed before or in parallel with the submission to Revista CEFAC. Authors need to cite the preprint in the manuscript, state in the Statement of Responsibility that the manuscript has been deposited in a preprint server, and provide the corresponding digital object identifier (DOI). For manuscripts that are accepted, the authors are requested to update the preprint with a link to the published article. |
Peer Review Process
Manuscript Evaluation Process All content published by Revista CEFAC is subject to peer review. The evaluation of manuscripts comprises three steps:
1. TECHNICAL EVALUATION:
2. SCOPE AND INTEREST ASSESSMENT:
3. DOUBLE-BLIND PEER REVIEW: Transparency in Peer Review Revista CEFAC offers the following options to enhance transparency in peer review, subject to mutual agreement between authors and reviewers:
These options are provided to authors, through the Open Science Compliance Form, during the submission process, and to reviewers during the review process. Adherence to these practices is optional and voluntary, with the aim of promoting an open and transparent review environment, while respecting the confidentiality preferences of those involved. Submissions from Editors and Editorial Board Members Manuscripts submitted to Revista CEFAC by its editors or by members of the editorial board undergo the same double-blind peer review process as submissions in general. The editor or member of the editorial board responsible for the authorship of the submitted article will not participate in any stage of the peer review process. Manuscripts submitted by editors or members of the editorial board are not given any priority over other manuscripts. Any editor or editorial board member listed as an author of a submitted manuscript is required to declare their affiliation with the journal in the manuscript’s “Conflicts of Interest” section. Appeals and Withdrawals If any editorial decision is doubted or contested, then the author(s) can contact the editors in chief, who will provide their justifications, clarify any doubts in the process, and confirm the status of the manuscript as being accepted or rejected for publication. Manuscripts may not be submitted for consideration in other national or international journals while they are undergoing editorial evaluation in Revista CEFAC. In the case of any doubts about the evaluation process, the author(s) should contact the editors in chief by email at revistacefac@cefac.br. After Acceptance and the Publishing Process When a manuscript has been accepted for publication, the corresponding author will receive an electronic message regarding payment. Payment should be issued to the Associação Brasileira de Motricidade Orofacial (ABRAMO) account at Banco Itaú, Agência 4271 C/C 23820-8 – CNPJ 022.196.630/0001-16. Authors who do not live in Brazil can issue payment via PayPal after completing the form available at https://abramofono.com.br/produto/taxa-de-publicacao-para-a-revista-cefac/. Proof of deposit has to be emailed to revisora1@revistacefac.br, along with the name and ID of the person for whom the receipt has to be issued. The issue in which the article is to be published is chosen upon receipt of proof of payment. For further information, please contact us at revisora1@revistacefac.br. After a manuscript’s acceptance, the author(s) will be requested to send the English version of the manuscript. For more information, see “Language Policy.” |
Open Data
Data Sharing Policy Revista CEFAC encourages authors to share their research data if doing so does not violate the protection of human rights or other valid privacy concerns. Authors may use their institution's data repository, SciELO Data, or other repository options, such as those available at re3data.org or in the SciELO recommended repositories list. Upon submitting manuscripts, authors need to provide a data sharing statement on the Title Page. The data sharing statement needs to indicate whether the research data will be shared and, if so, then (1) what data in particular will be shared, (2) when the data will become available and for how long, and (3) by what access criteria data will be shared. Examples of data sharing statements are provided by the International Committee of Medical Journal Editors (ICMJE) at https://icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html#two. |
Fees
Publication Fees Revista CEFAC does not charge any submission fee. There is a publication fee of BRL $900.00 to be paid by authors whose articles have been accepted for publication. Translation costs are not included with the publication fee. The cost of an article’s translation to English is the responsibility of authors. |
Ethics and Misconduct, Correction and Retraction Policy
Revista CEFAC observes the “Guidelines on Best Practices for Strengthening Ethics in Scientific Publication” recommended by SciELO(1), which promote integrity and transparency in the dissemination and reproducibility of research, and the “Core Practices” of the Committee on Publication Ethics - COPE(2). Responsibilities and Duties of Editors, Referees, and Authors Revista CEFAC complies with ethical standards and good practices, including COPE’s “Core Practices”: available at https://publicationethics.org/core-practices, which editors in chief follow and recommend associate editors, referees, and authors to also read and follow. Authors need to read, complete, and submit the Statement of Responsibility during the submission of the manuscript.
Declaration of Responsibilities and Duties of Editors, Referees, and Authors(1-5)
Responsibilities and Duties of Referees:
Responsibilities and Duties of Authors:
Corrections and Retractions Revista CEFAC consistently observes a policy of correction to ensure the quality of articles, and follows the SciELO guidelines for the registration, markup, and publication of errata, retractions, and addenda. Editors have a strong commitment to clarify, prevent, and correct any errors made by authors and even those made by other editors or resulting from the editing process. Authors, readers, and editors are encouraged to report errors in articles by emailing the editors of the journal at revistacefac@cefac.br. Revista CEFAC accepts comments and criticisms regarding published articles written in a constructive, objective, and educational manner. The author(s) of criticized articles or containing errors will be notified and afforded the opportunity to publish responses to the comments, criticisms, and/or clarification of errors. The editorial board observes that policy in order to ensure that the conduct of its editors aligns with ethics in publication. |
Policy on Conflict of Interest
Conflict of interest may be of a personal, commercial, political, academic, or financial nature. Conflicts of interest can occur between authors, reviewers, or editors. There is a potential conflict of interest for the reviewers or editors in situations in which they identify or suspect that they have participated or intend to participate in the development of the manuscript submitted for their evaluation; maintain or have maintained regular scientific collaboration in research activities or publications with any of the researchers responsible for the manuscript submitted for their evaluation; have commercial or financial interests in the development of the manuscript submitted for their evaluation; have a family relationship with one of the researchers responsible for the manuscript submitted for their evaluation; or have any kind of relationship that can be reasonably perceived as compromising the objectivity and impartiality of their evaluation in relation to one of the authors responsible for the manuscript submitted for their evaluation(2). There is a potential conflict of interest for authors in situations in which their necessary interest in advancing and their interests of another nature, even if legitimate, can reasonably be perceived, by themselves or others, as conflicting and harmful to the objectivity and impartiality of their scientific decisions, regardless of their knowledge and will(2). |
Adoption of Similarity Software
Revista CEFAC values the maintenance of good scientific practices and publication ethics. All articles, following an initial technical evaluation, will be forwarded for similarity analysis using the Crossref Similarity Check by iThenticate to detect plagiarism. It should be noted that plagiarism is a crime punishable by Brazilian law. Fraudulent information or plagiarism is not accepted. In the case that plagiarism or self-plagiarism is detected, the author(s) will be notified, and the journal will adopt the retraction measures guided by SciELO(1), COPE(3) and the ICMJE. |
Adoption of Software Using Artificial Intelligence Resources
AI tools and resources that assist authors in preparing their manuscripts can be used, provided that they are employed with ethical and scientific integrity and adhere to attribution norms. Revista CEFAC follows the recommendations of the World Association of Medical Editors (WAME), regarding ethical issues related to the use of generative Artificial Intelligence (AI) and AI-assisted technologies in scientific manuscripts and the Guide for Using AI Tools and Resources in Research Communication in the SciELO Network. The recommendations include:
- Authors should disclose the use of generative AI and AI-assisted technologies in the manuscript preparation process, providing detailed information (name, version, model, and source) about how the technology was applied and its contribution to the development of the manuscript. Authors should add a statement at the end of the main manuscript file, before the References section. Model of Statement on Generative AI and AI-Assisted Technologies in the Writing Process: During the preparation of this work, the author(s) used [NAME OF TOOL/SERVICE] for [PURPOSE]. After using this tool/service, the author(s) reviewed and edited the content as needed and assume full responsibility for the content of the publication. Revista CEFAC does not use artificial intelligence software in the evaluation of manuscripts. When the manuscript received is not a preprint, editors and reviewers should not submit the manuscript to services that could cause the leakage of identities and content. |
Gender and Sex Issues
The editorial team of Revista CEFAC, as well as the authors who publish in this journal, must follow the Guidelines on Sex and Gender Equity in Research (SAGER). The terms "sex" (biological attribute) and "gender" (shaped by social and cultural circumstances) should be used in accordance with the principles of these guidelines. |
Ethics Committee
During manuscript submission, authors must attach the approval from the institutional ethics committee responsible for approving the research. Human and Animal Rights
Revista CEFAC requires authors to follow the recommendations proposed by the ICMJE and published in the article “Uniform Requirements for Manuscripts Submitted to Biomedical Journals,” published in February 2006 and available at http://www.icmje.org/
It should be clearly stated in the manuscript that all participants provided their informed consent prior to their inclusion in the study. It is also mandatory to provide the approval letter of the ethics committee of the institution where the research was conducted. Participants’ anonymity should be maintained. Information about and images of individual participants will be published only if the individual’s prior informed consent has been obtained. For manuscripts reporting studies with animals, a statement indicating that the protocol and procedures employed were ethically reviewed and approved has to be included in the “Methods.” Authors should state whether experiments were performed in accordance with relevant guidelines for the care and use of laboratory animals—for example:
Clinical Trials Revista CEFAC supports the policies of the World Health Organization (WHO) (https://www.who.int/clinical-trials-registry-platform/network/primary-registries) and the ICMJE (https://www.icmje.org/) for registering clinical trials, in recognition of the importance of those initiatives for the registration and international dissemination of information on clinical trials via open access. A clinical trial is any study that prospectively assigns humans to intervention or comparison groups to evaluate the cause and effect between a medical intervention and a health-related outcome. Clinical trials are required to be registered in a relevant clinical trial registration system, including: |
Copyright
Authors of articles published by Revista CEFAC retain the copyright of their work, licensing it under the Creative Commons Attribution CC BY 4.0 license, which allows the articles to be reused and distributed without restriction, as long as the original work is properly cited. Authors grant the journal the right of first publication. |
Intellectual Property and Terms of Use
Website’s Responsibilities:
Author’s Responsibilities:
|
Sponsors and Promotion Agencies
Sponsor
Editorial Office and Contact Information |
Editors-in-Chief
|
Associate Editors
|
Editorial Committee
|
Special Consultants
|
Editorial Production
|
Selection of and Changes to the Editorial Board
The selection of editorial board members is based on their expertise in areas within the journal’s scope of interest, completion of a doctoral degree, experience as a reviewer for scientific journals, and recommendations from other members of the editorial board. The editors in chief annually review the makeup of editorial board by evaluating each board member’s contributions and, on that basis, retaining or replacing them as members of the editorial board. |
Functions of the Editorial Board
Functions of the editors in chief:
Functions of the associate editors:
Functions of the editorial committee:
|
General Policies
Manuscript Submission Only articles submitted to the online publishing system will be considered for publication. The system may be accessed at https://mc04.manuscriptcentral.com/rcefac-scielo. Advertising Policy Revista CEFAC currently does not reproduce or publish advertisements. Its sole purpose is to disseminate scientific articles related to different areas of speech-language pathology and audiology and their interfaces with other areas of knowledge. |
Types of Documents Accepted
Revista CEFAC accepts original research articles, literature review articles, brief communications, clinical case reports, and letters to the editor. Revista CEFAC accepts manuscripts that have been deposited in a non-commercial preprint server. For more information, see the Preprints section. Manuscripts can be submitted in Portuguese, English, or Spanish. |
Section Policies
Original Research: Original Research articles disseminate the new results of scientific research, whether quantitative or qualitative. Their formal structure has to include six sections: “Introduction,” “Methods,” “Results,” “Discussion,” “Conclusion,” and “References.” The maximum number of references allowed is 40, 70% of which need to be articles published in national and international journals, preferably in the past five years. If a greater number of references is required, then the editors may be consulted. Subheadings, citations of clinical implications, and limitations of the study, particularly in the “Discussion” section of the article, are recommended. The “Methods” section needs to state the research’s approval by an ethics committee and the case number, whenever appropriate, along with the registration number of the protocol used (i.e., for clinical trials). The section also needs to describe the study’s design, the study’s setting, the participants, any interventions performed, and clinical outcomes of interest. The abstract should not exceed 200 words in length and should contain the following sections: “Purpose,” “Methods,” “Results,” and “Conclusion.” Literature Reviews: Literature Reviews, including integrative, systematic, and scoping reviews, provide critical reviews of a topic of scientific interest within speech-language pathology, audiology, or related areas and offer new insights into the topic, point out gaps of knowledge on the topic, raise new topics of discussion, and/or indicate paths to be studied in the future. Other types of literature reviews will be accepted at the discretion of the editors. The formal structure of all Literature Reviews needs to include the following: “Introduction,” which justifies the topic of the review, including the clinical question to be answered and the objective to be met; “Methods,” which contains information regarding the registration of the protocol in databases such as the International Prospective Register of Systematic Reviews (PROSPERO) or Open Science Framework (OSF), presents the eligibility criteria, the Patient, Intervention, Comparison, and outcome (PICO) strategy or Population, Concept, and Context (PCC) strategy, the inclusion and exclusion criteria, the databases consulted, the strategies for searching for literature (e.g., manual search), details of the process of data collection, how the quality of reviewed studies was assessed, risks of bias when relevant, the method of data analysis, the outcomes studied, and, when meta-analysis is present, the method used to perform it; “Literature Review,” which has to contain a flow chart showing how literature was selected for the review, a summary of qualitative and quantitative data, the results of the meta-analysis with forest plots when applicable, and, when relevant, the results concerning the risks of bias, methodological quality, and the risk analysis of the studies included in the review, along with a discussion of the results found; “Conclusion,” which has to objectively answer the research question(s) studied; and “References,” containing a maximum of 40 references to articles published in national and international journals. If a greater number of references is required, then the editors may be consulted. The abstract should not exceed 200 words and should contain the following sections: “Purpose,” “Methods,” “Literature Review,” and “Conclusion.” Systematic review articles registered in PROSPERO (https://www.crd.york.ac.uk/prospero/) are preferred. The scientific writing of systematic reviews should follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist, while the writing of scoping reviews should follow the PRISMA for Scoping Reviews (PRISMA-ScR) checklist. Literature review protocols will be accepted in the category of Literature Reviews but only in cases in which the data extraction has not begun. The protocols need to contain the following sections: “Introduction,” containing the research question(s), hypothesis, and objectives; “Methods,” containing a description of PICO or PCC, eligibility criteria, sources of information, the search strategy, data selection and extraction, outcomes, the risk of bias assessment, data synthesis, meta-analysis when applicable, and the assessment of certainty of evidence; “Discussion,” containing the relevance, weaknesses, and strengths of the proposed revision; and “Final Considerations.” Literature review protocols registered on other platforms need to report the registration number in the “Methods” section. Protocols have to include all items and be accompanied by the PRISMA for Protocols (PRISMA-P) checklist. The abstract has to be structured, not exceed 200 words in length, and contain the following sections: “Purpose,” “Methods,” and “Final Considerations.” Brief Communications: Brief reports of research or professional experience with methodologically appropriate evidence, although manuscripts describing new methods or techniques will also be considered. The formal structure of Brief Communications has to include the following: “Introduction,” “Methods,” “Results,” “Discussion,” “Final Considerations” (or “Conclusions”), and “References.” The abstract has to be structured, not exceed 200 words in length, and contain the following sections: “Purpose,” “Methods,” “Results,” and “Final Considerations” (or “Conclusions”).
Case Reports: Reports of rare or uncommon cases that are particularly interesting or that yield new knowledge and/or showcase treatment techniques or reflections. Case Reports have to be original and unpublished. It is necessary to present the research ethics committee’s approval and to ensure the confidentiality of the case participant’s identity. The formal structure of Case Reports has to include the following: a succinct “Introduction” with support from the literature that justifies the presentation of the case; a “Case Report” containing a description of the history, procedures, and treatments performed; “Results,” which need to clearly show the progress achieved; “Discussion”; “Conclusion” (or “Final Considerations”); and “References” containing no more than 30 references to articles published in national and international journals, preferably in the past five years. The abstract should not exceed 200 words and should not be structured. The scientific writing of clinical case reports needs to follow the recommendations of the Case Report (CARE) Guidelines for the consensus-based reporting of clinical cases. |
Language Policy
Revista CEFAC accepts the submission of articles written in English, Portuguese, or Spanish. If an article is accepted for publication, then an English version is mandatory and has to be certified by a specialized company or translator that is responsible for it (declaration form presented below). All authors are fully responsible for the content of their manuscripts, as well as for the translation of their manuscripts into English by a qualified translator. The cost of translation to English is the responsibility of authors. A declaration certifying the English version of an accepted article has to be sent along with the article using the following form:
DECLARATION OF ENGLISH PROOFREADING |
Authors' Contribution
Authorship Criteria Every person designated as an author of a submitted manuscript should have sufficiently participated in its production to justify taking public responsibility for its content. Authorship credit has to be based on (1) substantial contributions to the conception and design of the research, to the collection of data, or to the analysis and interpretation of data; (2) participation in drafting the manuscript or critically revising it for important intellectual content; and (3) the final approval of the version to be published. Each author assumes responsibility for the scientific quality of the work as a whole, as well as professional, public, ethical, and social responsibility of its publication. Editors may request justification when the total number of authors exceeds eight. The author responsible for the submission of the manuscript has to provide the Open Researcher and Contributor ID (ORCID) of each author. If an author is not registered, then it is possible to register upon the submission of the article at https://orcid.org/. Authors’ Contributions Authors’ contributions have to be indicated on the Title Page using the Contributor Roles Taxonomy defined at https://credit.niso.org/contributor-roles-defined/. Possible contributions are conceptualization, data curation, formal analysis, funding acquisition, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing – original draft, and writing – review & editing. Changes in Authorship If authors request the removal or addition of one or more authors after the submission or publication of a manuscript, then they are required to send an explanation and statement of agreement for the requested change signed by all listed authors and from the author(s) to be removed or added. Acknowledgments
The “Acknowledgments” section needs to name collaborators whose contributions to the article do not justify authorship and acknowledge all forms of financial support and technical aid received. The contributions of all contributors and providers of support have to be specified. The corresponding author has to submit written permission to be acknowledged from each individual named in the “Acknowledgments”. |
Manuscript Preparation
Reporting Guidelines Authors are encouraged to consult the guidelines relevant to their specific research design on Equator Network. For randomized clinical trials, authors should consult the Consolidated Standards of Reporting Trials (i.e., CONSORT) statement; for observational studies, the Strengthening the Reporting of Observational Studies in Epidemiology (i.e., STROBE) statement; and, for diagnostic studies, the Standards for Reporting Studies of Diagnostic Accuracy (i.e., STARD). Which guidelines are appropriate to follow depends on the type of study conducted, and other or additional guidelines may be used. Submission Files Required
In short, the Title Page should state the following in the following order:
The manuscript may not exceed 15 pages in length (i.e., from “Introduction” until and excluding “References”), has to be single-spaced, and may include up to 10 tables or figures. Questionnaires can be included as supplementary materials.
Statement of Responsibility Template
|
Manuscript Preparation Guidelines
Article Submission Format
Below the abstract, three to six keywords should be listed that capture the topic of the study. All keywords need to be based on the Descritores em Ciências da Saúde [Descriptors in Health Sciences] (https://decs.bvsalud.org/) published by Bireme, which is a translation of the Medical Subject Headings (https://www.ncbi.nlm.nih.gov/mesh/) of the National Library of Medicine. For clinical trials, the registration number at the Clinical Trial Registration base should be provided after the abstract.
The “Introduction” needs to contain data that introduce the topic to the reader in a clear, concise way. The objective of the research needs to be clearly stated in the last paragraph of the section—for example, “The objective(s) of the study was (were) to” etc.—and needs to match the objective stated in the abstract. The “Methods” section needs to describe the methods used in detail. The section also has to state the research’s approval by a research ethics committee when applicable, specify the inclusion and exclusion criteria, and clearly describe the procedures to enable the replication of the study and a complete understanding of what and how it was accomplished. The relevant protocols to understand the methods also need to be incorporated into the section, and the section needs to state the theoretical approach on which the research was based including protocols adapted by the author(s) or used in full. The “Methods” also needs to present the type of statistical analysis used (i.e., descriptive and/or inferential) and describe the software used, the statistical tests applied, and the level of significance assigned. Ideally, descriptive results should be summarized in tables or figures when convenient, and, in that case, the data presented should not be repeated in graphics or the text.
|
Digital Assets
Tables should be self-explanatory, avoid references to the text and other tables, and be numbered consecutively with Arabic numerals in the order in which they appear in the text. Each table should be presented with table number and title at the top, entirely in capital letters, without a period and aligned with the left edge of the table. Below each table, the same title alignment needs to be used to present the caption for the table, any statistical tests (i.e., with test name and p value), and the source from which the information was obtained when not the author(s). The layout should be simple, with top, bottom, and division lines between the header row and the other rows in bold. External vertical lines should not be included, and diagonal divisions inside the cells of the table are not allowed.
Each figure needs to be submitted as an attachment in the submission system, in .TIF or .JPG format, with a minimum resolution of 300 dpi. Consideration should be given to the maximum width of the journal, which is 16.5 cm. Figures can be colored or black and white (i.e., grayscale). They need to be saved and named according to the article and their order within it—for example, “articleX_fig_1” and “articleX_fig_2” etc. Before-and-after images should be taken with the same intensity, direction, and color of light. Radiological and other clinical and diagnostic images, pictures of pathology specimens and photomicrographs should be sent as high-resolution photographic image files. Photomicrographs should have internal scale markers, with symbols, arrows, and letters contrasting with the background. The internal scale should be explained and the method of staining identified. Captions of figures should appear under the figures, not within them. When statistical tests are shown, the test name, p value, and source from which the information was obtained when the source is not the author(s) needs to be provided. In the case of graphs formatted in Excel, the original files (i.e., .xls) from which the graphs were created need to be provided. For still images, details with arrows, letters, numbers, and/or symbols, if provided, should be clear and large enough to withstand reduction. If a figure has previously been published, then the author or authors need to cite the original source and submit the written consent of the publisher and the original author(s) for its use. |
Citations and References
References need to be formatted in Vancouver style, as shown in the examples below. All authors should be listed with their last or family names, and only the first letter of those names is to be capitalized, followed by the initials of given name(s) without periods. For all references, the first six authors should be mentioned; if there are more than six authors, then the first six authors should be mentioned followed by “et al.” Whenever available, the titles of sources should be in English. The titles of journals need to be abbreviated in accordance with the List of Journals Indexed in Index Medicus of the National Library of Medicine, available at: https://www.nlm.nih.gov/index.html. References to theses, dissertations, or papers presented at scientific conferences should be avoided. Personal communications, unpublished research, and studies in progress may be cited when absolutely necessary but should not be included in the references. Whenever possible, include the DOI of every reference and its PubMed Unique Identifier (PMID). Citations should be made using Arabic numerals in superscript, in sequential numerical order, avoiding the inclusion of author names. If citations are sequential, they should be separated by a hyphen. If they are non-sequential, separation should be done using commas. Preferably, use references from indexed journals published in the last five years. Journal articles
Author(s) of the article. Title of the article. Abbreviated title of the journal. Year of publication; volume (issue): initial–final pages of the article. DOI if available. Journal article without authors
Title of the article. Abbreviated title of the journal. Year of publication; volume (number): initial–final pages of the article.
Books Chapters in edited collections
Author(s) of the chapter. Title of the chapter. In: Name(s) of author(s) or editor(s). Title of the collection. Edition. City of publication: Publisher; Year of publication. Initial–final pages of the chapter. Note: For the city of publication, the abbreviation of the state or province can also be added between parentheses—for example, “Berkeley (CA).” If it is a country, then it can be added in full—for example, “Adelaide (Australia).” If the book is the first edition, there is no need to identify the edition. The edition number should use the abbreviation in English—for example, “4th ed.” Conference proceedings
Author(s) of the article. Title of the article. Title of the event; date of the event; place of the event. City of publication: Publisher; Year of publication. Conference papers
Author(s) of the article. Title of the presented article. In: Editor(s) responsible for the event (if any). Title of the Event: Proceedings of the Title of the Event; date of the event; place of the event. City of publication: Publisher; Year of publication. Initial–final pages of the article. Dissertations, theses, and course completion assignments
Author. Title of the study [Type of document]. City of the institution (state): institution; Year the study was formally presented at the institution. Unpublished sources (in press)
Author(s) of the article. Title of the article. Abbreviated title of the journal. In press, probable year of publication after acceptance. Audiovisual materials
Author(s). Title of the material [Media type]. City of publication: Publisher; year. Webpages
Author(s) of the website (if any). Title of the webpage [webpage on the Internet]. City: Institution; Date(s) of registration* [date of last update with the expression “updated on”; access date with the expression “accessed on”]. Website address with the expression “Available at:” followed by the URL.
Author(s) of the database (if any). Title [database on the Internet]. City: Institution; date(s) of registration [date of last update with the expression “updated on” if any; access date with the expression “accessed on”]. Website address with the expression “Available at:” followed by the URL. |
Supplementary Documents
The supplementary documents requested from authors during manuscript submission are:
|
Financing Statement
Authors must disclose the sources of support used for the development of the work, including the names of sponsors, contract numbers (if applicable), along with explanations of the role of these sources. |
Additional Information
References
1. SCIELO. Guia de boas práticas para o fortalecimento da ética na publicação científica, 2018 [viewed 5 April 2020]. Available from: https://wp.scielo.org/wp-content/uploads/Guia-de-Boas-Praticas-para-o-Fortalecimento-da-Etica-na-Publicacao-Cientifica.pdf |
Contact
ABRAMO - Associação Brasileira de Motricidade Orofacial |